Search

Honey bees are facing many serious threats, and Varroa destructor is of major worldwide concern. V. destructor was first observed in 2010 in the south–west Inidan Ocean island of Madagascar. Varroa spp. was first suspected in Mauritius in late July 2014. Two surveys were conducted in September and November 2014 in Mauritius and Rodrigues. The aims of these surveys were to confirm the presence of Varroa on Mauritius, determine the species and strain and to study its spread and interactions with the bee louse Braula pretoriensis. Honey bees were sampled from different sites. V. destructor and the bee louse Braula pretoriensis infestation rates were measured for each colony and apiary. V. destructor presence was confirmed and observed in the Central and Northern part of Mauritius, but was not detected in Rodrigues. B. pretoriensis was observed on both islands. V. destructor partial mitochondrial region of the CO1 showed that the Mauritius K strain found was different from the one from Madagascar. In Mauritius, B. pretoriensis numbers were significantly higher in colonies infested by V. destructor; however, bee louse infestation rates were similar in both islands in sites without the varroa mite. Although bee louse population regulation by honey bees is unknown, individual and social behaviors regulating V. destructor populations within colonies are not sufficient to maintain low levels of both B. pretoriensis and V. destructor. Sanitary measures were proposed, some of which are currently being applied to limit the spread of V. destructor across the island.

Foot-and-mouth disease (FMD) is a highly contagious disease of livestock affecting animal production and trade throughout Asia and Africa. Understanding FMD virus (FMDV) global movements and evolution can help to reconstruct the disease spread between endemic regions and predict the risks of incursion into FMD-free countries. Global expansion of a single FMDV lineage is rare but can result in severe economic consequences. Using extensive sequence data we have reconstructed the global space-time transmission history of the O/ME-SA/Ind-2001 lineage (which normally circulates in the Indian sub-continent) providing evidence of at least 15 independent escapes during 2013–2017 that have led to outbreaks in North Africa, the Middle East, Southeast Asia, the Far East and the FMD-free islands of Mauritius. We demonstrated that sequence heterogeneity of this emerging FMDV lineage is accommodated within two co-evolving divergent sublineages and that recombination by exchange of capsid-coding sequences can impact upon the reconstructed evolutionary histories. Thus, we recommend that only sequences encoding the outer capsid proteins should be used for broad-scale phylogeographical reconstruction. These data emphasise the importance of the Indian subcontinent as a source of FMDV that can spread across large distances and illustrates the impact of FMDV genome recombination on FMDV molecular epidemiology.

International audience; The circulation of West Nile virus (WNV) in horses was investigated in the Southwest Indian ocean. In 2010, blood samples were collected from a total of 303 horses originating from Madagascar, Mauritius, Reunion and the Seychelles and tested for WNV-specific antibodies. An overall seroprevalence of 27.39% was detected in the Indian Ocean with the highest WNV antibody prevalence of 46.22% (95% CI: [37.4–55.2%]) in Madagascar. The age and origin of the horses were found to be associated with the WNV infection risk. This paper presents the first seroprevalence study investigating WN fever in horses in the Southwest Indian Ocean area and indicates a potential risk of infection for humans and animals. In order to gain a better understanding of WN transmission cycles, WNV surveillance needs to be implemented in each of the countries.

Background Few serological tests are available for detecting antibodies against Mycoplasma capricolum subsp. capripneumoniae, the causal agent of contagious caprine pleuropneumonia (CCPP). The complement fixation test, the test prescribed for international trade purposes, uses a crude antigen that cross-reacts with all the other mycoplasma species of the “mycoides cluster” frequently infecting goat herds. The lack of a more specific test has been a real obstacle to the evaluation of the prevalence and economic impact of CCPP worldwide. A new competitive ELISA kit for CCPP, based on a previous blocking ELISA, was formatted at CIRAD and used to evaluate the prevalence of CCPP in some regions of Kenya, Ethiopia, Mauritius, Tajikistan and Pakistan in an international collaborative study. Results The strict specificity of the test was confirmed in CCPP-free goat herds exposed to other mycoplasma species of the “mycoides cluster”. Prevalence studies were performed across the enzootic range of the disease in Africa and Asia. Seroprevalence was estimated at 14.6% in the Afar region of Ethiopia, whereas all the herds presented for CCPP vaccination in Kenya tested positive (individual seroprevalence varied from 6 to 90% within each herd). In Mauritius, where CCPP emerged in 2009, nine of 62 herds tested positive. In Central Asia, where the disease was confirmed only recently, no positive animals were detected in the Wakhan District of Afghanistan or across the border in neighboring areas of Tajikistan, whereas seroprevalence varied between 2.7% and 44.2% in the other districts investigated and in northern Pakistan. The test was also used to monitor seroconversion in vaccinated animals. Conclusions This newly formatted CCPP cELISA kit has retained the high specificity of the original kit. It can therefore be used to evaluate the prevalence of CCPP in countries or regions without vaccination programs. It could also be used to monitor the efficacy of vaccination campaigns as high-quality vaccines induce high rates of seroconversion.

The Animal Risk regional network: surveillance and research in the Indian Ocean. To meet the challenges of emerging diseases in the Indian Ocean region, in 2009 animal health stakeholders set up the Animal Risk-OI network, designed to provide technicaland scientific support to surveillance systems and to suggest ways of improving health risk control in the area. The network is supported by OIE referring bodies for the Indian Ocean—veterinary services and animal health research organizations. Animal Risk-OI is not intended to replace current monitoring systems but to help consider arising issues through bimonthly webconferences, annual meetings and quarterly newsletters, and to provide information for research aiming to clarify theepidemiology of certain diseases and recommend suitable control measures. This paper presents the preliminary findings following the monitoring and investigation of diseases considered by network partners to be of top priority. Apart from pursuing synergy between surveillance and research activities, the network aims to bridge the gap between animal and human health to instigate ajoint, standardized approach to the assessment and control of health risks in the Indian Ocean region., Pour répondre aux défis lancés par les maladies émergentes dans l’Océan Indien, les acteurs de la santé animale ont mis en place depuis début 2009 le réseau AnimalRisk-OI. Ce réseau a pour objectif d’apporter un soutien technique et scientifique aux systèmes de surveillance et de proposer des réponses pour une meilleure gestion des risques sanitaires dans la zone. Les partenaires sont les référents de l’OIE dans l’Océan Indien, à savoir les services vétérinaires ainsi que les structures de recherché impliquées en santé animale. Le réseau AnimalRisk-OI n’a pas pour vocation de se substituer aux systèmes de surveillance existants, mais il est chargé d’animer une réflexion autour des problématiques observées par des téléweb conférences bimensuelles, des réunions annuelles et des bulletins d’information trimestriels et de nourrir des actions de recherche qui visent à mieux comprendre l’épidémiologie de certaines maladies et donc de proposer des mesures de gestion adéquates pour mieux les maîtriser. Les premiers résultats de la surveillance et des investigations sur certaines maladies considérées prioritaires par les partenaires sont présentés ici. Les orientations envisagées, outre la poursuite de la synergie entre les actions de surveillance et de recherche, sont un rapprochement avec la santé humaine pour permettre une approche commune et harmonisée de l’appréciation et de la gestion des risques sanitaires dans l’Océan Indien.